Technology, Consumer Staples, Healthcare Jan 25, 2022 06:29 PM (GMT+8) · EqualOcean
Maiwei biological announced that the company expects a net loss of 666 million yuan to 782 million yuan in 2021. During the reporting period, all products under research of the company were in the research and development stage, and commercial sales had not been carried out, and the sales revenue of the company's products had not been realized. During the reporting period, the company's main business income was mainly technical service income.
Related companies: